Health Economics Manager, CVRM (9-months Secondment/FTC)
AstraZeneca · London, United Kingdom · Global
Pharma Strategy
–
Not yet analysed
Demand72
Career growth65
Healthcare fit58
Remote potential50
5-year outlook
Experienced HEOR and market access professionals generally have strong pharma compensation prospects, but this is a short fixed-term/secondment role with no guaranteed permanent conversion. Long-term value depends on using the HTA modelling and submission experience to move into permanent HEOR or market access roles.
Clinical license
Not required
Applicant reach
narrow
Seniority
mid
Employment type
full-time
Date found
2026-11-09
Intelligence details
Flexible work details
- Engagement type
- Permanent
- Hours
- Full-time
- Eligible countries
- United Kingdom
Eligibility, licensing, and location restrictions can change. Always confirm details on the source posting before applying.
Why this is worth applying to
Worth considering only if you already have health economics/HTA modelling experience and want pharma market access exposure in CVRM. Clinicians without a HEOR or health economics background should usually build that evidence base first rather than apply directly.
Who should apply
Doctors, pharmacists, or healthcare graduates with a postgraduate health economics qualification and prior HTA/HEOR modelling experience who want to move into pharmaceutical market access. Also relevant for clinicians already working in HEOR agencies, payer evidence, or market access who want a short-term pharma secondment.
CV angle
Frame real clinical and therapeutic-area experience alongside any health economics education, HTA submissions, cost-utility or budget impact modelling, Excel/VBA work, payer evidence, systematic review/network meta-analysis exposure, and cross-functional project delivery. Emphasise experience writing evidence sections, responding to technical queries, and communicating with non-clinical stakeholders; do not claim HEOR modelling experience unless genuinely held.
Skills to highlight
- Health economic modelling
- Cost-utility analysis
- Budget impact analysis
- Microsoft Excel and VBA
- HTA submissions and payer evidence
- Market access strategy
- Cross-functional communication
- Systematic literature review and network meta-analysis
Role summary
Lead UK HTA health economic content for AstraZeneca's CVRM portfolio, including building and adapting cost-utility and budget impact models in Excel, writing cost-effectiveness submission sections for NICE/SMC/AWMSG, responding to assessor questions, and representing the company at appraisal committees.
We publish our own intelligence summary, never the full job description. Always confirm details with the employer when you apply.